Publications by authors named "Antonis Fanouriakis"

Claim this Profile
E
EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update.
Antonis Fanouriakis, Myrto Kostopoulou, Hans-Joachim Anders, Jeanette Andersen, Martin Aringer

Ann Rheum Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparable 12-month renal response outcomes with medium vs. high-dose starting prednisone in a real-world study of lupus nephritis.
Maria Pappa, Sofia Flouda, Antigone Pieta, Spyridon Katechis, Myrto Nikoloudaki, Antonis Fanouriakis

Rheumatology (Oxford)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic lupus erythematosus damage risk index (SLE-DRI): a simple machine learning-based tool for identifying patients at risk for early organ damage.
Panagiotis Garantziotis, Dionysis Nikolopoulos, Spyridon Katechis, Alp Temiz, Danae-Mona Nöthling, Antonis Fanouriakis

RMD Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosus.
Dionysis Nikolopoulos, George Sentis, Iasonas Kitsios, Panagiotis Garantziotis, Noemin Kapsala, Antonis Fanouriakis

Ann Rheum Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Lupus Check 5 Tool: A Practical Approach to Initiating Treatment Reviews in Systemic Lupus Erythematosus.
Anca Askanase, Antonis Fanouriakis, Lyra Agustin, Maria Dall'Era, Marta Mosca

Rheumatol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations.
Laurent Arnaud, Guillermo Ruiz-Irastorza, Cynthia Aranow, Sasha Bernatsky, Maria Dall'Era, Antonis Fanouriakis

Lancet Rheumatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent-relapsing SARS-CoV-2 infection following rituximab treatment for autoimmune rheumatic diseases: diagnosis and outcomes.
Katerina Chavatza, Elisavet Mastrostamati, Charalampos Charalampidis, Elvira-Markela Antonogiannaki, Ioannis Grigoropoulos, Antonis Fanouriakis

RMD Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lupus Enteritis and Rare Severe Manifestations of Lupus: Why Classification Criteria should not be used for Diagnosis.
Antonis Fanouriakis

Mediterr J Rheumatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation.
Spyridon Katechis, Dionysis Nikolopoulos, Sofia Flouda, Christina Adamichou, Katerina Chavatza, Antonis Fanouriakis

Rheumatology (Oxford)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxychloroquine for all patients with lupus nephritis: yes.
Maria Pappa, Dimitrios T Boumpas, Antonis Fanouriakis

Nephrol Dial Transplant· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can conventional brain MRI support the attribution process in neuropsychiatric SLE? A multicentre retrospective study.
Ettore Silvagni, Antonio Marangoni, Carlo Garaffoni, Simone Appenzeller, George Bertsias, Antonis Fanouriakis

Lupus Sci Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular markers of microangiopathy and their possible association with cardiovascular risk in patients with systemic inflammatory rheumatic diseases: a systematic review.
Bengta Sturm, Anna-Lena Zang, Julia Stingl, Rebecca Hasseli-Fräbel, Antonis Fanouriakis

Front Immunol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum CXCL-13 levels are associated with active neurological involvement in patients with systemic lupus erythematosus.
Derya Yildirim, Abdulsamet Erden, Antonis Fanouriakis, Handenur Koc Kanik, Hakan Babaoglu

Lupus· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptome analysis to decipher the molecular underpinnings of response to treatment in systemic lupus erythematosus.
Panagiotis Garantziotis, Georgia Savina Moysidou, Noemin Kapsala, Sofia Flouda, Dionysis Nikolopoulos, Antonis Fanouriakis

RMD Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways.
Georgia-Savina Moysidou, Panagiotis Garantziotis, George Sentis, Dimitra Nikoleri, Nikolaos Malissovas, Antonis Fanouriakis

Ann Rheum Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study.
Spyridon Katechis, Sofia Pitsigavdaki, Myrto Nikoloudaki, Ettore Silvagni, Argyro Repa, Antonis Fanouriakis

RMD Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations.
Myrto Kostopoulou, Chetan B Mukhtyar, George Bertsias, Dimitrios T Boumpas, Antonis Fanouriakis

Ann Rheum Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anifrolumab for systemic lupus erythematosus with multi-refractory skin disease: A case series of 18 patients.
Sofia Flouda, Evgenia Emmanouilidou, Anastasios Karamanakos, Dimitra Koumaki, Dimitrios Katsifis-Nezis, Antonis Fanouriakis

Lupus· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to: Correspondence on 'EULAR recommendations for the management of systemic lupus erythematosus: 2023 update' by Fanouriakis .
Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas

Ann Rheum Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mediterranean diet and exercise are associated with better disease control in psoriatic arthritis.
Pelagia Katsimbri, Alexandros Grivas, Evangelia Papadavid, Kimon Tzannis, Sofia Flouda, Antonis Fanouriakis

Clin Rheumatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational study.
Maria Pappa, Maria Kosmetatou, Antigone Pieta, Myrto Nikoloudaki, Nektarios Marios Liapis, Antonis Fanouriakis

RMD Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NYMERIA Study: A Real-World, Multicentre Contemporary Assessment of Disease- and Patient-Related Burden and Treatment Strategies in Patients with Systemic Lupus Erythematosus.
George Bertsias, Antonis Fanouriakis, Marina Bartsakoulia, Petros Galanakis, Dimitrios T Boumpas

Mediterr J Rheumatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Trials of Interferon Inhibitors in Systemic Lupus Erythematosus and Preliminary Real-World Efficacy of Anifrolumab.
Samuel Díaz-Planellas, Dimitrios Katsifis-Nezis, Antonis Fanouriakis

Mediterr J Rheumatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Multiple Faces of Systemic Lupus Erythematosus: Pearls and Pitfalls for Diagnosis.
Noemin Kapsala, Dionysis Nikolopoulos, Antonis Fanouriakis

Mediterr J Rheumatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EULAR 2023 Recommendations for the Management of Systemic Lupus Erythematosus: One Step Forward.
Georgia-Savina Moysidou, Antonis Fanouriakis

Mediterr J Rheumatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis